Clinical effectiveness of Resin modified calcium silicate cements

Abstract

A thorough and critical analysis of basic properties of resin modified calcium silicate cements has been made. The problems related to the cytotoxicity and mineralization potential of this group of materials have been tracked. An important question that remains in the dental literature is whether these materials are suitable for direct pulp capping. The aim is to examine the data in the literature regarding the longterm clinical effectiveness of resin modified calcium silicate cements in direct pulp capping. A literature search base was undertaken in three electronic databases: PubMed, EBSCOhost and Google Scholar for the period 2015–2026. Resin modified calcium silicate cements belong to the fourth generation. These are materials that harden by light polymerization and hydration reaction. Issues related mainly to their cytotoxicity, bioactivity and clinical effectiveness were considered. The available information in the dental literature mainly concerns TheraCal LC. There are comparative data on the cytotoxicity of TheraCal PT and conventional calcium silicate cements. For most of the new forms of resin modified calcium silicate cements, main information is from the manufacturers. Further studies on their cytotoxicity and bioactivity need to be done. An important conclusion that emerges from the analysis of the literature data is the need for definitive studies on the
long-term clinical effectiveness of these materials as a means for direct pulp capping.